Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Shahin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurosurgery|November 17, 2018
Presence of Histopathological Treatment Effects at Resection of Recurrent Glioblastoma: Incidence and Effect on OutcomeCecilia L Dalle Ore, Ankush Chandra, Jonathan Rick, et al.
Critical Reviews in Oncology/Hematology|July 30, 2019
Systemic therapy for brain metastasesJonathan W Rick, Maryam Shahin, Ankush Chandra, et al.
Innate Immunity|September 25, 2019
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastomaSharareh Gholamin, Osama A Youssef, Marjan Rafat, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurosurgery|November 17, 2018
Presence of Histopathological Treatment Effects at Resection of Recurrent Glioblastoma: Incidence and Effect on OutcomeCecilia L Dalle Ore, Ankush Chandra, Jonathan Rick, et al.
Critical Reviews in Oncology/Hematology|July 30, 2019
Systemic therapy for brain metastasesJonathan W Rick, Maryam Shahin, Ankush Chandra, et al.
Innate Immunity|September 25, 2019
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastomaSharareh Gholamin, Osama A Youssef, Marjan Rafat, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
Pageof 1